Premium
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosis
Author(s) -
Kramer Mario W.,
Escudero Diogo O.,
Lokeshwar Soum D.,
Golshani Roozbeh,
Ekwenna Obi O.,
Acosta Kristell,
Merseburger Axel S.,
Soloway Mark,
Lokeshwar Vinata B.
Publication year - 2010
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.25565
Subject(s) - hyaluronic acid , medicine , immunohistochemistry , bladder cancer , lymph node , pathology , hyaluronan synthase , cancer , metastasis , anatomy
BACKGROUND: Cancer biomarkers are the backbone for the implementation of individualized approaches to bladder cancer (BCa). Hyaluronic acid (HA) and all 7 members of the HA family, that is, HA synthases (HA1, HA2, HA3), HYAL‐1 hyaluronidase, and HA receptors (CD44s, CD44v, and RHAMM), function in tumor growth and progression. However, the diagnostic and prognostic potential of these 7 HA family members has not been compared simultaneously in any cancer. We evaluated the diagnostic and prognostic potential of HA family members in BCa. METHODS: Using quantitative PCR and immunohistochemistry, expression of HA family members was evaluated in prospectively collected bladder tissues (n = 72); mean and median follow‐up were 29.6 ± 5.3 and 24 months, respectively. Transcript levels were also measured in exfoliated urothelial cells from urine specimens (n = 148). RESULTS: Among the HA family members, transcript levels of the HA synthases, HYAL‐1, CD44v, and RHAMM were 4‐ to 16‐fold higher in BCa tissues than in normal tissues ( P < .0001); however, CD44s levels were lower. In univariate and multivariate analyses, tumor stage ( P = .003), lymph node invasion ( P = .033), HYAL‐1 ( P = .019), and HAS1 ( P = .027) transcript levels, and HYAL‐1 staining ( P = .021) were independently associated with metastasis. Tumor stage ( P = .019) and HYAL‐1 ( P = .046) transcript levels were also associated with disease‐specific mortality. Although HA synthase and HYAL‐1 transcript levels were elevated in exfoliated urothelial cells from BCa patients, the combined HAS2–HYAL‐1 expression detected BCa with an overall sensitivity of 85.4% and a specificity of 79.5% and predicted BCa recurrence within 6 months ( P = .004; RR = 6.7). CONCLUSIONS: HYAL‐1 and HAS1 expression predicted BCa metastasis, and HYAL‐1 expression also predicted disease‐specific survival. Furthermore, the combined HAS2–HYAL‐1 biomarker detected BCa and significantly predicted its recurrence. Cancer 2011. © 2010 American Cancer Society.